Latest filing published 26 Jan 2022 for RIGEL PHARMACEUTICALS INC.
Insider track record
No signal scores available.
Dolly Vance: trading record in brief
Dolly Vance is a declared insider of Rigel Pharmaceuticals Inc (chief executive), with filings sourced from SEC (Form 4). We count 4 filings; the first trade dates from 13 September 2012 and the latest from 24 January 2022.
On the market, this insider has only sold: 3 sales, €37k in total. The rest of the record consists of 1 share grant.
Most recently, on 26 January 2022, the filings show a share grant in Rigel Pharmaceuticals Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Dolly Vance
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 50,000 shares0Common StockSEC:0001567619-22-001778:0
- 1,000 shares@ US$2.22Common StockSEC:0001179110-14-018587:0
- 4,151 shares@ US$10.43Common StockSEC:0001179110-12-014075:0
3 of 3 declarations
